With 30 years of leadership experience in both technology and pharmaceuticals, Innes Meldrum brings an authentic, charismatic, cross-cultural leadership approach to successfully deliver business
growth through highly engaged organizations.
Meldrum is President and CEO of Reset Pharma, a New York based Clinical stage, Neuro Biotechnology company focused on developing Psychedelics to treat Mental Health issues associated with
life threatening diseases. In this role, Meldrum leads all operational, development and fund-raising activities.
Prior to this role, Meldrum was Chief Commercial Officer for Otsuka Pharma North America. Growing revenue 32% to $2.5B, increasing operating income 68% to $940M and simultaneously improving employee engagement to 84% (~20% above pharma industry norm) while delivering a strategic transformation of the commercialization model.
Before entering Healthcare he spent 10 years leading businesses in the tech. industry.
growth through highly engaged organizations.
Meldrum is President and CEO of Reset Pharma, a New York based Clinical stage, Neuro Biotechnology company focused on developing Psychedelics to treat Mental Health issues associated with
life threatening diseases. In this role, Meldrum leads all operational, development and fund-raising activities.
Prior to this role, Meldrum was Chief Commercial Officer for Otsuka Pharma North America. Growing revenue 32% to $2.5B, increasing operating income 68% to $940M and simultaneously improving employee engagement to 84% (~20% above pharma industry norm) while delivering a strategic transformation of the commercialization model.
Before entering Healthcare he spent 10 years leading businesses in the tech. industry.
Speaking In
4:15 PM - 4:30 PM
Monday, June 5
